arrow
A

Andrea Surcinelli

santa maria delle croci hospital
H指数:13
被引数:527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intravenous and intra-arterial thrombolysis for acute ischemic stroke following interventional cardiac procedures: A systematic review and narrative synthesis

经介入心脏手术后急性缺血性卒中的静脉和动脉内溶栓治疗:一项系统评价和叙述性综合

2026-10-280
PRE
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study

在记录有化疗暴露的人群中,癌症诊断后的多发性硬化结局:一项真实世界MSBase研究

2026-08-020
PRE
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

在复发缓解型多发性硬化中,针对临床静息期MRI病灶的治疗升级

Brain
IF11.7
2026-07-240
OAAI
Causal effects of multiple sclerosis therapies in left-truncated registry data

多发性硬化疗法在左截断登记数据中的因果效应

2026-07-210
PRE
Predicting disease progression in multiple sclerosis with clinically accessible information and technology

利用临床可获取的信息和技术预测多发性硬化症的疾病进展

2026-04-190
OAAI
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry

抗CD20疗法与S1P受体调节剂在迟发性多发性硬化中的比较疗效:来自MSBase注册研究的真实世界证据

2026-03-260
PRE
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry

迟发性对多发性硬化表型和结局的影响:多国注册研究的证据

2026-02-040
PRE
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing–Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study
2026-01-280
PRE
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry

多发性硬化疾病 modifying therapies 之间水平切换的实效性:MSBase 注册数据库的回顾性分析

2025-12-230
PRE
Harmonized magnetic resonance imaging protocols for multiple sclerosis: HARMONY-MS, a pilot project

多发性硬化症的标准化磁共振成像方案:HARMONY-MS,一项试点项目

2025-12-220
PRE
Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study

复发缓解型多发性硬化中独立于复发和与复发相关的残疾进展的性别差异:一项真实世界逆概率加权研究

2025-09-230
OA
Persistent progression independent of relapse activity in multiple sclerosis

多发性硬化中与复发活动无关的持续性进展

2025-08-210
OAAI
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

造血干细胞移植与免疫重建疗法在复发型多发性硬化中的比较

Brain
IF11.7
2025-08-040
PRE
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

四年之后:MSBase妊娠、新生儿结局及女性健康登记册(2020–2024)中报告的妊娠与分娩结局

2025-07-070
PRE
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study

低丙种球蛋白血症和严重感染在应用抗CD20制剂的多发性硬化患者中的研究:一项多中心研究

2025-01-012
OAAI
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
2024-09-040
PRE